Clarke Brannen Futch

Founder at Healthcare Royalty Management LLC

Clarke Brannen Futch

Clarke Brannen Futch

Founder at Healthcare Royalty Management LLC

Overview
Career Highlights

Healthcare Royalty Management LLC
Thomas Weisel Partners Group, Inc.

RelSci Relationships

2394

Number of Boards

8

Birthday

1967

Age

53

Contact Data
Trying to get in touch with Clarke Brannen Futch? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Clarke Brannen Futch likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at Cowen Healthcare Royalty Management LLC

Relationship likelihood: Strong

Founder at Healthcare Royalty Management LLC

Relationship likelihood: Strong

Partner at 1315 Capital LLC

Relationship likelihood: Strong

Founder at Nuron Biotech, Inc.

Relationship likelihood: Strong

Partner at Healthcare Royalty Management LLC

Relationship likelihood: Strong

Senior Advisor at L.E.K. Consulting LLC

Relationship likelihood: Strong

Former Chief Executive Officer at Den-Mat Holdings LLC

Relationship likelihood: Strong

Partner & Chief Medical Officer at Healthcare Royalty Management LLC

Relationship likelihood: Strong

Chief Financial Officer at Healthcare Royalty Management LLC

Relationship likelihood: Strong

Partner at Healthcare Royalty Management LLC

Relationship likelihood: Strong

Paths to Clarke Brannen Futch
Potential Connections via
Relationship Science
You
Clarke Brannen Futch
Founder at Healthcare Royalty Management LLC
Education
BA, magna cum laude
Class of 1989

Vanderbilt University is a center for scholarly research, informed and creative teaching, and service to the community and society at large. Vanderbilt will uphold the highest standards and be a leader in the quest for new knowledge through scholarship, dissemination of knowledge through teaching and outreach, and creative experimentation of ideas and concepts. In pursuit of these goals, Vanderbilt values most highly the intellectual freedom that supports open inquiry and equality, compassion and excellence in all endeavors.

J.D.

Founded by Thomas Jefferson in 1819, the University of Virginia School of Law is a world-renowned training ground for distinguished lawyers and public servants. Consistently ranked among the top law schools in the nation, Virginia has educated generations of lawyers, instilling in them a commitment to leadership, integrity and community service. Virginia is justly famous for its collegial environment that bonds students and faculty, and student satisfaction is consistently cited as among the highest in American law schools. At Virginia, law students share their experiences in a cooperative spirit, both in and out of the classroom, and build a network that lasts well beyond their three years here. With more than 20,000 students and a faculty of more than 2,100, the University of Virginia has been ranked first or second among the nation's public universities since 1984. The University's diverse intellectual life is open to law students: Up to 12 credits from other departments may be counted toward the J.D. degree.

Career History
Founder
2006 - Current

Healthcare Royalty Management invests primarily in commercial stage healthcare companies, pharmaceutical, biotechnology and products through the purchase of traditional passive royalties, the creation of synthetic royalties, structured debt and equity instruments. The firm focus on healthcare companies and products across a broad range of therapeutic areas predominately in the US and European Union. They targets investments of $20 million to $200 million. They provides financing capital to assist in the transfer of product and execution risk, finance new development opportunities, acquire new products or technologies, fund additional capital needs and monetize product royalties.

Founder
Tenure Unconfirmed

Thomas Weisel Partners Group, Inc. is an investment banking company. It provides investment banking, brokerage, equity research and asset management services. Its clients come from technology, healthcare and consumer sector industries. The company's equity research focuses on technology, healthcare and consumer sectors. Asset management division includes private equity and distribution management. The company was founded in 1998 and is headquartered in San Francisco, CA.

Vice President
Tenure Unconfirmed

Founded in 1962, Raymond James & Associates, Inc. (RJA) is a broker/dealer headquartered in St. Petersburg, Florida. The firm is a subsidiary of Raymond James Financial, Inc. (NYSE: RJF), a Florida-based diversified holding company that provides financial services to individuals, corporations and municipalities through 3 wholly-owned broker/dealers: Raymond James & Associates, Raymond James Financial Services and Raymond James Ltd. RJA was originally known as Robert A. James Investment, Inc. In 1964, Edward Raymond sold his St. Petersburg-based company, Raymond & Associates, to Robert James. The new company was named Raymond James & Associates.Raymond James is one of the largest research organizations in the brokerage industry and serves institutional investors domestically and abroad. The firm's capital markets activities are based on insightful, timely and comprehensive equity research. They publish research on over 1,000 companies in their core industries. Raymond James seeks attractive niches within broader industries and then covers these sectors deeply to develop differentiated sector expertise and relationships. Although their focus is mid- and small-cap companies, their coverage includes large, medium and small companies across each sector.Raymond James' Institutional Trading division is organized into 3 specialty departments: Sales Trading, Principal trading and Agency Trading. Their Sales Trading division covers over 800 domestic and 1,300 international financial institutions throughout North America and Europe. The firm's Principal Trading division consists of industry-focused teams and their OTC Principal Trading department makes markets in over 680 domestic stocks, 85% of which are covered by Raymond James Institutional Research department. Their Agency Trading department services the trading needs of over 5,500 financial advisors located in 2,500 retail offices across the US.RJA's equity research department focuses on industries in the consumer, energy, financial services, healthcare, industrial growth, real estate, technology and telecommunications sectors. Their fixed-income research and strategy team provides corporate, structured products and analytics, municipal and economic research to individual and institutional investors.

Boards & Committees
Member, Investment Committee
2007 - Current

Healthcare Royalty Management invests primarily in commercial stage healthcare companies, pharmaceutical, biotechnology and products through the purchase of traditional passive royalties, the creation of synthetic royalties, structured debt and equity instruments. The firm focus on healthcare companies and products across a broad range of therapeutic areas predominately in the US and European Union. They targets investments of $20 million to $200 million. They provides financing capital to assist in the transfer of product and execution risk, finance new development opportunities, acquire new products or technologies, fund additional capital needs and monetize product royalties.

Director
Current

Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA.

Director
Current
Political Donations
$2,500
2012

Senator at Office of the Senator from Utah, Mitt Romney

$250
1995

Senator from Tennessee

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Clarke Brannen Futch. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Clarke Brannen Futch's profile does not indicate a business or promotional relationship of any kind between RelSci and Clarke Brannen Futch.